Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating

Source: Market Watch | Published: September 29, 2025, 9:36 am | Read Original

Bearish -50.0

Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating

Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Glideslope AI

Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating

Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.

Market Watch • Sep 29, 2025 • Found on Glideslope.ai

Post hash: 82380859761645013626 • glideslope.ai/post/82380859761645013626

Sentiment

Bearish • Score: -50.0

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

JPMorgan tries to get off hook for $115M in legal bills for cons who scammed them out of $175M

JPMorgan is stuck paying for Charlie Javice's legal fees. The bank says her $115 million bill is 'patently excessive and egregious'

Coinbase stock surges after JPMorgan upgrade on Base, USDC potential

JPMorgan reportedly plans to let clients borrow against their Bitcoin and Ether

JPMorgan upgrades Coinbase, saying the shares are cheap and a 25% rally is ahead

Michael Dell seems very happy about JPMorgan's new $3 billion office, and a single photo shows why